# US Coronary Pressure Monitors Market

> US Coronary Pressure Monitors Market Research Report By Device (Sphygmomanometer, Automated Blood Pressure Monitor, BP Transducers, Ambulatory Blood Pressure Monitor) and By End User (Hospitals & Clinics, Home Healthcare, Others) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.93%
- **2024:** $ 6.85 Billion
- **2025:** $ 7.32 Billion
- **2035:** $ 14.31 Billion
- **Key Players:** Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic plc (IE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Johnson & Johnson (US), Terumo Corporation (JP)

**Report ID:** MRFR/MED/17794-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** May 13, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-coronary-pressure-monitors-market-19341

---

## Market Summary

## **US Coronary Pressure Monitors Market Overview**

As per MRFR analysis, the US Coronary Pressure Monitors Market Size was estimated at 6.23 (USD Billion) in 2023. The US Coronary Pressure Monitors Market Industry is expected to grow from 6.85(USD Billion) in 2024 to 12.33 (USD Billion) by 2035. The US Coronary Pressure Monitors Market CAGR (growth rate) is expected to be around 5.496% during the forecast period (2025 - 2035).

### **Key US Coronary Pressure Monitors Market Trends Highlighted**

In the US Coronary Pressure Monitors Market, significant market drivers include the increasing prevalence of cardiovascular diseases, which have been a growing concern due to lifestyle factors and an aging population. The demand for real-time monitoring of patients' cardiovascular health has led to technological advancements in coronary pressure monitoring devices, emphasizing their capabilities for remote patient monitoring and telehealth applications. Innovations such as wireless monitors and integration with digital health records are enhancing patient management and accessibility.

Opportunities in this market can be captured by focusing on the development of advanced technologies that improve the accuracy and convenience of coronary pressure monitoring.The push from healthcare providers for improved clinical outcomes is driving the adoption of these devices, and there is a clear market opportunity for manufacturers to create user-friendly solutions that cater to both clinical and at-home settings. Trends in recent times highlight a gradual shift towards preventive healthcare, prompting patients and providers to seek better management tools for cardiovascular risks.

Regulatory support from agencies like the FDA has streamlined the approval processes for new medical devices, enabling quicker access to innovative solutions.

Additionally, there is an increasing emphasis on personalized medicine, pushing manufacturers to tailor their products to meet specific patient needs.Overall, these dynamic trends reflect a market that is adapting to the evolving healthcare landscape in the US, focusing on improving patient outcomes through advanced technology and innovative practices.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Coronary Pressure Monitors Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases**

The rise in the prevalence of cardiovascular diseases (CVDs) in the United States is a significant driver for the US Coronary Pressure Monitors Market Industry. According to the American Heart Association, nearly 48% of adults in the United States have some form of cardiovascular disease, which accounted for over 697,000 deaths in 2020 alone. This alarming statistic suggests a growing demand for advanced monitoring solutions, such as coronary pressure monitors, to manage and treat CVDs effectively.

As healthcare providers increasingly focus on early diagnosis and managing high-risk patients, the usage of these monitors is anticipated to surge. Major organizations like the Centers for Disease Control and Prevention (CDC) are implementing initiatives aimed at improving heart health awareness and promoting better monitoring practices, thereby creating a favorable environment for the growth of the US Coronary Pressure Monitors Market.

### **Technological Advancements in Medical Devices**

Rapid advancements in technology are playing a pivotal role in enhancing the functionalities of coronary pressure monitors, making them more appealing to healthcare professionals. Innovations such as wireless connectivity, real-time data transmission, and integration with electronic health records are enhancing patient monitoring and management capabilities. According to the Food and Drug Administration, there has been a notable increase in the number of medical device approvals, particularly for cardiac devices, which enables healthcare professionals to utilize state-of-the-art technology for better patient outcomes.

Furthermore, significant companies in the sector, such as Medtronic and Abbott, are investing heavily in Research and Development (R&D) to develop cutting-edge coronary pressure monitors. This focus on innovation is expected to drive market growth in the US, as healthcare facilities look to utilize the latest technologies in patient care.

### **Government Initiatives and Funding for Cardiovascular Health**

Government initiatives aimed at improving cardiovascular health play a crucial role in driving the growth of the US Coronary Pressure Monitors Market Industry. The U.S. Department of Health and Human Services has implemented various programs and funding strategies to promote cardiovascular health and reduce the burden of CVDs in the country. The National Heart, Lung, and Blood Institute, in particular, has increased its budget allocations for cardiovascular-related research, which aims to foster innovation in monitoring devices.

According to the FY2022 budget estimates, the investment in heart disease research was highlighted as a priority, receiving substantial funding for research initiatives and grants. This backing not only enhances the development of new technologies for coronary pressure monitoring but also facilitates widespread adoption across healthcare systems, bolstering overall market growth.

### **Growing Geriatric Population in the US**

The increasing geriatric population in the United States is contributing significantly to the growth of the US Coronary Pressure Monitors Market. By 2030, it is projected that 20% of the US population will be over 65 years old, reflecting an increase of approximately 18 million individuals. The elderly demographic is particularly susceptible to cardiovascular conditions, necessitating effective monitoring solutions. The availability of coronary pressure monitors becomes crucial for this age group to ensure timely intervention and management of their health.

Healthcare facilities are responding to this demographic change by investing in advanced monitoring technologies, making significant strides in chronic disease management. Key organizations like the Administration for Community Living are advocating for improved health strategies for older adults, further promoting the need for innovative solutions in the coronary pressure monitoring space.

## **US Coronary Pressure Monitors Market Segment Insights**

### **Coronary Pressure Monitors Market Device Insights**

The Device segment of the US Coronary Pressure Monitors Market has been experiencing substantial developments, contributing significantly to the overall market dynamics. This segment encompasses various types of devices that are essential for monitoring arterial pressure, which is crucial for diagnosing and treating cardiovascular conditions. The Sphygmomanometer remains a fundamental tool in clinical settings, providing healthcare professionals with reliable manual blood pressure readings and playing a key role in hypertension management.

Their integration into sophisticated monitoring systems highlights their importance in ensuring patient safety during surgical procedures and inpatient care. Additionally, Ambulatory Blood Pressure Monitors have transformed hypertension evaluation by allowing continuous monitoring over a 24-hour period, providing a more comprehensive understanding of a patient's blood pressure patterns throughout the day and night. This technology supports better treatment plans and enhances patient outcomes, demonstrating its significant role in proactive healthcare management. The growth of the device segment is driven by increasing awareness of cardiovascular diseases and the need for effective monitoring solutions.

As the aging population in the US rises and the prevalence of chronic conditions increases, the demand for these innovative devices is expected to see further growth, positioning the US Coronary Pressure Monitors Market as a vital area of focus for healthcare innovation and improvement.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Coronary Pressure Monitors Market End User Insights**

The End User segment of the US Coronary Pressure Monitors Market plays a crucial role in the overall functioning and growth of the industry. Within this segment, hospitals and clinics are significant users, primarily due to their need for precise monitoring of cardiovascular health in critical care settings. They require advanced monitoring equipment to manage patients with coronary ailments effectively.

This segmentation reflects a diverse usage of coronary pressure monitors across different healthcare settings, highlighting the growing demand for continuous and remote monitoring solutions in the US healthcare landscape. The continuous evolution of technology and increasing healthcare expenditure further suggest that these end users will heavily influence the market dynamics and trends in the coming years.Furthermore, the rise in cardiovascular diseases in the US is a substantial driver, motivating investments in better monitoring solutions across all end user categories.

## **US Coronary Pressure Monitors Market Key Players and Competitive Insights**

The US Coronary Pressure Monitors Market is characterized by a dynamic competitive landscape, where numerous players vie for market visibility and share by leveraging innovation and technological advancements. This market is critical as it supports healthcare providers in diagnosing and managing coronary arterial conditions, thereby facilitating improved patient outcomes. The competitive insights reveal that companies are investing significantly in research and development to create sophisticated monitoring devices that offer enhanced accuracy and user-friendliness.

Collaboration and strategic partnerships are common strategies employed by these firms to expand their market reach and enhance product offerings, ensuring they stay ahead in a rapidly evolving industry.

Omron Healthcare holds a robust position within the US Coronary Pressure Monitors Market, focusing its efforts on delivering high-quality monitoring solutions. The company is recognized for its commitment to innovation and has established a strong reputation for producing reliable and easy-to-use devices tailored for both clinical and home use. One of the key strengths of Omron Healthcare lies in its extensive distribution network, which ensures that its products are readily available to healthcare professionals and patients alike across the United States.

The brand is synonymous with reliability in blood pressure monitoring, and its emphasis on consumer education around cardiovascular health helps solidify its standing in a competitive market. Furthermore, Omron's dedication to enhancing user experience through advanced technology and seamless integration with digital health platforms illustrates its proactive approach to meet the evolving needs of healthcare providers and patients.

C.R. Bard, on the other hand, also plays a significant role in the US Coronary Pressure Monitors Market, providing a range of products and services aimed at improving cardiovascular health management. The company is well-positioned in this space with its innovative offerings, which include specialized pressure monitoring devices designed for both in-hospital and outpatient settings. C.R. Bard is known for its emphasis on clinical excellence, regularly engaging in strategic mergers and acquisitions to enhance its product portfolio and expand its market reach.

These strategic moves have often allowed the company to incorporate cutting-edge technology and ultimately strengthen its position in the industry. With a commitment to extensive research and development, C.R. Bard continues to focus on delivering quality solutions and maintaining comprehensive support systems that appeal to healthcare providers in the US, thus ensuring competitive advantage.

### **Key Companies in the US Coronary Pressure Monitors Market Include**

### **US Coronary Pressure Monitors Market Industry Developments**

In the US Coronary Pressure Monitors Market, notable developments have emerged, particularly in the realm of innovation and mergers. Omron Healthcare and Medtronic have recently unveiled advanced pressure monitoring devices aimed at enhancing cardiovascular diagnostics, emphasizing their commitment to Research and Development. March 2023 saw Smiths Medical expanding its product line, leading to increased market valuation and competitive positioning.

Meanwhile, Abbott Laboratories announced intentions to acquire C.R. Bard in February 2023, which aligns with broader market trends of consolidation among major players. Also reported, Philips has introduced a new telemetry system for seamless cardiac monitoring, further solidifying its presence in the market.

Over the last two years, the rise in chronic cardiovascular diseases in the US prompted companies like GE Healthcare and Boston Scientific to ramp up their production capacities to meet escalating demand. FDA approvals for next-generation monitors from companies such as Nihon Kohden in January 2022 have also triggered investments towards enhancing operational efficiencies. Collectively, these factors underscore an optimistic growth trajectory for the US Coronary Pressure Monitors Market, driven by technological advancements and strategic acquisitions among key industry participants.

## **US Coronary Pressure Monitors Market Segmentation Insights**

### **Coronary Pressure Monitors Market Device Outlook**

### **Coronary Pressure Monitors Market End User Outlook**

## Market Drivers

### Increased Healthcare Expenditure

Rising healthcare expenditure in the US is a significant driver for the coronary pressure-monitors market. As healthcare budgets expand, there is a greater allocation of funds towards advanced medical technologies, including coronary pressure monitors. The US healthcare spending is projected to reach approximately $4.3 trillion by 2025, with a substantial portion directed towards cardiovascular care. This financial commitment indicates a robust market environment for coronary pressure-monitoring devices. The coronary pressure-monitors market is poised to thrive as healthcare providers invest in technologies that enhance patient care and improve clinical outcomes.

### Growing Focus on Preventive Healthcare

The shift towards preventive healthcare is driving the coronary pressure-monitors market. With an increasing emphasis on early detection and management of health issues, healthcare providers are investing in advanced monitoring technologies. This trend is supported by initiatives aimed at reducing healthcare costs and improving patient outcomes. The coronary pressure-monitors market is likely to benefit from this focus, as more patients are encouraged to monitor their cardiovascular health proactively. The market is projected to expand as healthcare systems adopt these technologies to facilitate preventive measures, potentially reducing the burden of chronic diseases.

### Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases in the US is a primary driver for the coronary pressure-monitors market. According to the CDC, heart disease remains the leading cause of death, accounting for approximately 697,000 deaths annually. This alarming statistic underscores the urgent need for effective monitoring solutions. As healthcare providers seek to enhance patient outcomes, the demand for coronary pressure monitors is expected to rise. The market is projected to grow at a CAGR of around 6.5% over the next five years, driven by the necessity for early detection and management of heart conditions. Consequently, the coronary pressure-monitors market is likely to experience substantial growth as healthcare systems prioritize cardiovascular health.

### Technological Innovations in Monitoring Devices

Technological advancements in medical devices are significantly influencing the coronary pressure-monitors market. Innovations such as wireless connectivity, real-time data transmission, and advanced algorithms for data analysis are enhancing the functionality of these monitors. The integration of artificial intelligence and machine learning is also improving predictive analytics, allowing for better patient management. As of 2025, the market for smart coronary pressure monitors is expected to reach approximately $1.2 billion, reflecting a growing trend towards more sophisticated monitoring solutions. These innovations not only improve patient outcomes but also streamline clinical workflows, making them a vital component of the coronary pressure-monitors market.

### Regulatory Support for Innovative Medical Devices

Regulatory support for innovative medical devices is fostering growth in the coronary pressure-monitors market. The FDA has streamlined the approval process for new monitoring technologies, encouraging manufacturers to develop advanced solutions. This regulatory environment is conducive to innovation, allowing for quicker market entry of new products. As a result, the coronary pressure-monitors market is likely to see an influx of novel devices that meet the evolving needs of healthcare providers. The supportive regulatory framework not only enhances competition but also ensures that patients have access to the latest monitoring technologies.

## Future Outlook

The [Coronary Pressure Monitors Market](https://www.marketresearchfuture.com/reports/coronary-pressure-monitors-market-4768) is projected to grow at a 6.93% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

**New opportunities:**

- Development of portable coronary pressure-monitoring devices for home use. Integration of AI analytics for real-time patient monitoring solutions. Expansion into telehealth platforms for remote patient management.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand.

## Segment Insights

### By Device: Sphygmomanometer (Largest) vs. Automated Blood Pressure Monitor (Fastest-Growing)

In the US coronary pressure-monitors market, the Sphygmomanometer remains the largest segment, commanding a significant share of the market due to its long-standing presence and established trust among healthcare providers. Automated Blood Pressure Monitors, while second in market share, have rapidly gained popularity due to technological advancements and ease of use, creating a competitive landscape in the segment. However, the growth trends indicate that the Automated Blood Pressure Monitor is the fastest-growing category, driven by an increased preference for home monitoring and self-management of blood pressure. The rise in chronic conditions such as hypertension is propelling demand in this segment. Additionally, ongoing innovations and features that enhance user experience contribute to the significant growth trajectory of automated devices in this market.

Sphygmomanometer (Dominant) vs. Automated Blood Pressure Monitor (Emerging)

The Sphygmomanometer is recognized as the dominant technology in blood pressure measurement, known for its accuracy and reliability in clinical settings. Its traditional methodology continues to be favored by many healthcare professionals, particularly in hospitals and clinics. Conversely, the Automated Blood Pressure Monitor is emerging rapidly, appealing to a broader consumer base due to its convenience and ability to deliver quick readings. Enhanced features, such as Bluetooth connectivity and smartphone integration, are attracting tech-savvy users. This shift towards automated solutions is indicative of evolving consumer preferences, positioning them as a critical player in the US coronary pressure-monitors market.

### By End User: Hospitals & Clinics (Largest) vs. Home Healthcare (Fastest-Growing)

The distribution of the US coronary pressure-monitors market by end user reveals that hospitals and clinics account for the largest share, reflecting their critical role in patient care and advanced monitoring capabilities. Home healthcare is rapidly gaining traction, indicating a significant shift towards at-home patient management and monitoring solutions. This shift is driven by an increasing population of elderly patients and a growing preference for personalized healthcare services. Growth trends in this segment are fueled by technological advancements, increasing chronic disease prevalence, and a focus on reducing hospital visits. Hospitals and clinics continue to lead due to their established infrastructure, while home healthcare is emerging as the fastest-growing segment, supported by regulatory incentives and rising healthcare costs pushing patients towards home-based alternatives. This dual dynamic is reshaping the US coronary pressure-monitors market landscape.

Hospitals & Clinics (Dominant) vs. Home Healthcare (Emerging)

Hospitals and clinics are the dominant players in the coronary pressure-monitoring sector, benefiting from extensive facilities, trained professionals, and comprehensive patient care protocols. This segment leverages advanced technologies to ensure timely and accurate monitoring, essential for critical care scenarios. In contrast, home healthcare is classified as an emerging segment, driven by demand for convenience and personalized care solutions. The rise in telehealth and remote monitoring technologies is facilitating this growth. Home healthcare offers patients increased comfort and autonomy, making it particularly appealing to the aging population. As healthcare continues to evolve towards patient-centric models, both segments are crucial for the overall landscape of the US coronary pressure-monitors market.

## Competitive Benchmarking

The coronary pressure-monitors market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing emphasis on patient-centric healthcare solutions. Key players such as Abbott Laboratories (US), Boston Scientific Corporation (US), and Medtronic plc (IE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Abbott Laboratories (US) focuses on innovation, particularly in developing advanced monitoring technologies that integrate seamlessly with digital health platforms. Meanwhile, Boston Scientific Corporation (US) emphasizes strategic partnerships to expand its product offerings and enhance its market reach. Medtronic plc (IE) is actively pursuing mergers and acquisitions to bolster its portfolio, particularly in the realm of coronary pressure monitoring devices, thereby enhancing its competitive edge.The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains, which is crucial in a moderately fragmented market. This competitive structure allows for a diverse range of products and services, with key players collectively influencing market trends through their operational strategies. The presence of multiple strong competitors fosters innovation and drives improvements in product quality and service delivery.
In August Abbott Laboratories (US) announced the launch of a new coronary pressure-monitoring device that utilizes AI algorithms to provide real-time data analytics. This strategic move is significant as it positions Abbott at the cutting edge of technology, potentially enhancing patient outcomes and streamlining clinical workflows. The integration of AI into monitoring devices may also set a new standard in the industry, compelling competitors to innovate further.
In September Boston Scientific Corporation (US) entered into a partnership with a leading telehealth provider to enhance remote monitoring capabilities for coronary patients. This collaboration is indicative of a broader trend towards digital health solutions, allowing for improved patient engagement and continuous monitoring, which could lead to better management of coronary conditions. Such strategic alliances are likely to reshape the competitive landscape by integrating technology with traditional healthcare practices.
In October Medtronic plc (IE) completed the acquisition of a smaller firm specializing in advanced sensor technology for coronary pressure monitoring. This acquisition is pivotal as it not only expands Medtronic's technological capabilities but also enhances its product portfolio, allowing for more comprehensive solutions in coronary care. The move reflects a growing trend of consolidation in the market, where larger firms seek to integrate innovative technologies to maintain competitive differentiation.
As of November the competitive trends in the coronary pressure-monitors market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, shaping the landscape by fostering innovation and enhancing product offerings. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability, suggesting a transformative shift in how companies compete in this vital healthcare sector.

## Recent News & Developments

In the US Coronary Pressure Monitors Market, notable developments have emerged, particularly in the realm of innovation and mergers. Omron Healthcare and Medtronic have recently unveiled advanced pressure monitoring devices aimed at enhancing cardiovascular diagnostics, emphasizing their commitment to Research and Development. March 2023 saw Smiths Medical expanding its product line, leading to increased market valuation and competitive positioning.

Meanwhile, Abbott Laboratories announced intentions to acquire C.R. Bard in February 2023, which aligns with broader market trends of consolidation among major players. Also reported, Philips has introduced a new telemetry system for seamless cardiac monitoring, further solidifying its presence in the market.

Over the last two years, the rise in chronic cardiovascular diseases in the US prompted companies like GE Healthcare and Boston Scientific to ramp up their production capacities to meet escalating demand. FDA approvals for next-generation monitors from companies such as Nihon Kohden in January 2022 have also triggered investments towards enhancing operational efficiencies. Collectively, these factors underscore an optimistic growth trajectory for the US Coronary Pressure Monitors Market, driven by technological advancements and strategic acquisitions among key industry participants.

## Report Scope

| MARKET SIZE 2024 | 6.85(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 7.32(USD Billion) |
| MARKET SIZE 2035 | 14.31(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.93% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic plc (IE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Johnson & Johnson (US), Terumo Corporation (JP) |
| Segments Covered | Device, End User |
| Key Market Opportunities | Integration of advanced digital technologies enhances patient monitoring in the coronary pressure-monitors market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the coronary pressure-monitors market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US coronary pressure-monitors market in 2024?**
A: The market valuation was $6.85 Billion in 2024.

**Q: What is the projected market valuation for the US coronary pressure-monitors market by 2035?**
A: The projected valuation for 2035 is $14.31 Billion.

**Q: What is the expected CAGR for the US coronary pressure-monitors market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.93% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the US coronary pressure-monitors market?**
A: Key players include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Philips Healthcare, Siemens Healthineers, GE Healthcare, Johnson & Johnson, and Terumo Corporation.

**Q: What segment had the highest valuation in the device category in 2024?**
A: The Automated Blood Pressure Monitor had the highest valuation at $2.0 Billion in 2024.

**Q: What is the projected valuation for the Ambulatory Blood Pressure Monitor segment by 2035?**
A: The projected valuation for the Ambulatory Blood Pressure Monitor segment is $4.41 Billion by 2035.

**Q: How much did the Hospitals & Clinics segment generate in 2024?**
A: The Hospitals & Clinics segment generated $3.42 Billion in 2024.

**Q: What is the expected growth for the Home Healthcare segment by 2035?**
A: The Home Healthcare segment is expected to grow to $4.2 Billion by 2035.

**Q: What was the valuation of BP Transducers in 2024?**
A: The valuation of BP Transducers was $1.2 Billion in 2024.

**Q: What is the projected growth for the Others segment by 2035?**
A: The Others segment is projected to grow to $3.1 Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-coronary-pressure-monitors-market-19341*